# Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers

> **NCT02119091** · PHASE1 · UNKNOWN · sponsor: **Haiyan Li** · enrollment: 80 (estimated)

## Conditions studied

- Cardiac Toxicity

## Interventions

- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT02119091
- **Lead sponsor:** Haiyan Li
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119091, "Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02119091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*